Liver International

Cover image for Vol. 27 Issue 8

October 2007

Volume 27, Issue 8

Pages 1021–1156

  1. Review Article

    1. Top of page
    2. Review Article
    3. Meeting Report
    4. Basic Studies
    5. Clinical Studies
    6. Case Reports
    7. Letter to the Editor
    8. Erratum
    1. You have free access to this content
      Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways (pages 1021–1038)

      Stella Sun, Nikki P. Y. Lee, Ronnie T. P. Poon, Sheung-Tat Fan, Qing Y. He, George K. Lau and John M. Luk

      Version of Record online: 5 JUL 2007 | DOI: 10.1111/j.1478-3231.2007.01533.x

  2. Meeting Report

    1. Top of page
    2. Review Article
    3. Meeting Report
    4. Basic Studies
    5. Clinical Studies
    6. Case Reports
    7. Letter to the Editor
    8. Erratum
  3. Basic Studies

    1. Top of page
    2. Review Article
    3. Meeting Report
    4. Basic Studies
    5. Clinical Studies
    6. Case Reports
    7. Letter to the Editor
    8. Erratum
    1. Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis (pages 1045–1055)

      Ying-Ying Yang, Han-Chieh Lin, Yi-Tsau Huang, Tzung-Yan Lee, Ming-Chih Hou, Ying-Wen Wang, Fa-Yauh Lee and Shou-Dong Lee

      Version of Record online: 15 AUG 2007 | DOI: 10.1111/j.1478-3231.2007.01551.x

    2. Effect of phorbol ester and platelet-derived growth factor on protein kinase C in rat hepatic stellate cells (pages 1066–1075)

      Yoshimasa Kobayashi, Kim R. Bridle, Grant A. Ramm, Rosemary O'Neill, Robert S. Britton and Bruce R. Bacon

      Version of Record online: 20 AUG 2007 | DOI: 10.1111/j.1478-3231.2007.01573.x

    3. Significance of morphological alteration by portal vein branch ligation in endotoxin-induced liver injury after partial hepatectomy (pages 1076–1085)

      Shigeyasu Ota, Shohachi Suzuki, Takanori Sakaguchi, Satoshi Baba, Hiroshi Mitsuoka, Satoshi Nakamura and Hiroyuki Konno

      Version of Record online: 6 SEP 2007 | DOI: 10.1111/j.1478-3231.2007.01552.x

  4. Clinical Studies

    1. Top of page
    2. Review Article
    3. Meeting Report
    4. Basic Studies
    5. Clinical Studies
    6. Case Reports
    7. Letter to the Editor
    8. Erratum
    1. Development of autoimmune hepatitis in primary biliary cirrhosis (pages 1086–1090)

      Andrea A. Gossard and Keith D. Lindor

      Version of Record online: 16 AUG 2007 | DOI: 10.1111/j.1478-3231.2007.01538.x

    2. Serum C-reactive protein levels predict survival in hepatocellular carcinoma (pages 1091–1097)

      Sakae Nagaoka, Takafumi Yoshida, Junji Akiyoshi, Jun Akiba, Takuji Torimura, Hisashi Adachi, Junichi Kurogi, Nobuyoshi Tajiri, Kinya Inoue, Takashi Niizeki, Hironori Koga, Tsutomu Imaizumi, Masamichi Kojiro and Michio Sata

      Version of Record online: 15 AUG 2007 | DOI: 10.1111/j.1478-3231.2007.01550.x

    3. Incidence of psychiatric side effects during pegylated interferon- α retreatment in nonresponder hepatitis C virus-infected patients (pages 1098–1102)

      Lucas C. Quarantini, Rodrigo A. Bressan, Amanda Galvão, Susana Batista-Neves, Raymundo Paraná and Ângela Miranda-Scippa

      Version of Record online: 16 AUG 2007 | DOI: 10.1111/j.1478-3231.2007.01532.x

    4. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study (pages 1103–1110)

      Moon Young Kim, Soon Koo Baik, Dong Hun Park, Dae Wook Lim, Jae Woo Kim, Hyun Soo Kim, Sang Ok Kwon, Young Ju Kim, Sei Jin Chang and Samuel S. Lee

      Version of Record online: 13 JUN 2007 | DOI: 10.1111/j.1478-3231.2007.01526.x

    5. Efficacy of interferon alpha-2b induction therapy before retreatment for chronic hepatitis C (pages 1111–1118)

      Catherine Carr, F. Blaine Hollinger, Boris Yoffe, Adil Wakil, Jason Phillips, Natalie Bzowej, Janet Leung, Katherine Mirro, Fred Poordad, Dan H. Moore and Robert G. Gish

      Version of Record online: 15 AUG 2007 | DOI: 10.1111/j.1478-3231.2007.01535.x

    6. Health-related quality of life in patients with chronic hepatitis B (pages 1119–1125)

      Silvia Bondini, Jillian Kallman, Amy Dan, Zahra Younoszai, Lolita Ramsey, Fatema Nader and Zobair M. Younossi

      Version of Record online: 6 SEP 2007 | DOI: 10.1111/j.1478-3231.2007.01558.x

    7. Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma (pages 1126–1133)

      Maria Stella De Mitri, Romina Cassini, Sabrina Bagaglio, Giulia Morsica, Pietro Andreone, Nicoletta Marino and Mauro Bernardi

      Version of Record online: 16 AUG 2007 | DOI: 10.1111/j.1478-3231.2007.01537.x

    8. Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection (pages 1134–1143)

      Branwen J. Hennig, Angela J. Frodsham, Simon Hellier, Susanne Knapp, Leland J. Yee, Mark Wright, Lyna Zhang, Howard C. Thomas, Mark Thursz and Adrian V. Hill

      Version of Record online: 23 JUL 2007 | DOI: 10.1111/j.1478-3231.2007.01518.x

  5. Case Reports

    1. Top of page
    2. Review Article
    3. Meeting Report
    4. Basic Studies
    5. Clinical Studies
    6. Case Reports
    7. Letter to the Editor
    8. Erratum
    1. Suspected cross-hepatotoxicity of flutamide and cyproterone acetate (pages 1144–1147)

      Mireia Miquel, Aina Soler, Anna Vaqué, Isabel Ojanguren, Joan Costa and Ramon Planas

      Version of Record online: 6 SEP 2007 | DOI: 10.1111/j.1478-3231.2007.01549.x

    2. Fulminant liver failure secondary to haemorrhagic dengue in an international traveller (pages 1148–1151)

      James Gasperino, Jose Yunen, Alice Guh, Kathryn E. Tanaka, Vladimir Kvetan and Howard Doyle

      Version of Record online: 16 AUG 2007 | DOI: 10.1111/j.1478-3231.2007.01543.x

  6. Letter to the Editor

    1. Top of page
    2. Review Article
    3. Meeting Report
    4. Basic Studies
    5. Clinical Studies
    6. Case Reports
    7. Letter to the Editor
    8. Erratum
    1. Rimonabant as a novel therapeutic option for nonalcoholic steatohepatitis (pages 1152–1155)

      Matthias Banasch, Oliver Goetze, Wolfgang E. Schmidt and Juris J. Meier

      Version of Record online: 6 SEP 2007 | DOI: 10.1111/j.1478-3231.2007.01555.x

  7. Erratum

    1. Top of page
    2. Review Article
    3. Meeting Report
    4. Basic Studies
    5. Clinical Studies
    6. Case Reports
    7. Letter to the Editor
    8. Erratum
    1. You have free access to this content
      ERRATUM (page 1156)

      Version of Record online: 6 SEP 2007 | DOI: 10.1111/j.1478-3231.2007.01548.x

      This article corrects:

      A novel therapeutic drug (copper nicotinic acid complex) for non-alcoholic fatty liver

      Vol. 27, Issue 4, 454–464, Version of Record online: 9 MAR 2007

SEARCH

SEARCH BY CITATION